Strides gets USD20mn to grow its OTC business

5 November 2018 - Deborah Wilkes

Archived

Strides Pharma Science is set to receive private-equity funding worth USD20 million to grow its Consumer Healthcare business.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: